Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Elevance Health Q3 Adj. EPS $6.03 Beats $4.93 Estimate, Sales $50.087B Beat $49.369B Estimate

Author: Benzinga Newsdesk | October 21, 2025 05:01am
Elevance Health (NYSE:ELV) reported quarterly earnings of $6.03 per share which beat the analyst consensus estimate of $4.93 by 22.24 percent. This is a 29.88 percent decrease over earnings of $8.60 per share from the same period last year. The company reported quarterly sales of $50.087 billion which beat the analyst consensus estimate of $49.369 billion by 1.45 percent. This is a 12.00 percent increase over sales of $44.719 billion the same period last year.

Posted In: ELV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist